Table 3.
| A) Women | Framingham Risk Score | ||||
|---|---|---|---|---|---|
| Risk Categoryc | Low Risk | Intermediate Low Risk | Intermediate High Risk | High Risk | |
| Low risk | 3085 (54) | 336 (6) | 23 (<1) | 1 (< 1) | |
| ASCVD | Intermediate low risk | 530 (9) | 312 (5) | 65 (1) | 3 (< 1) |
| Intermediate high risk | 418 (7) | 299 (5) | 103 (2) | 9 (< 1) | |
| High risk | 203 (4) | 175 (3) | 112 (2) | 16 (< 1) | |
| B) Men | Framingham Risk Score | ||||
|---|---|---|---|---|---|
| Risk Categoryc | Low Risk | Intermediate Low Risk | Intermediate High Risk | High Risk | |
| Low risk | 667 (22) | 181 (6) | 4 (< 1) | 0 (0) | |
| ASCVD | Intermediate low risk | 207 (7) | 375 (12) | 51 (2) | 0 (0) |
| Intermediate high risk | 89 (3) | 361 (12) | 216 (7) | 10 (< 1) | |
| High risk | 50 (2) | 373 (12) | 419 (14) | 90 (3) | |
ASCVD atherosclerotic cardiovascular disease
Values are n (%)
Low risk ≤ 5%; Intermediate Low Risk 5% - ≤ 10%; Intermediate High Risk 10% - ≤ 20%; High Risk > 20%